Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

被引：9

作者：

Bernard, Sophie ^{[1
]}

Ghesquieres, Herve ^{[2
]}

Casasnovas, Rene-Olivier ^{[3
]}

Griolet, Samuel ^{[4
]}

da Silva, Maria Gomes ^{[5
]}

Feugier, Pierre ^{[6
]}

Morschhauser, Franck ^{[7
]}

Trotman, Judith ^{[8
,9
]}

Renaud, Loic ^{[1
]}

Greil, Richard ^{[10
]}

Martin Garcia-Sancho, Alejandro ^{[11
]}

Grosicki, Sebastian ^{[12
]}

van Eygen, Koen ^{[13
]}

Copie-Bergman, Christiane ^{[14
]}

Haioun, Corinne ^{[15
]}

Thieblemont, Catherine ^{[1
,16
]}

机构：

[1] Hop St Louis, Assistance Publ Hop Paris, Hematooncol, Paris, France

[2] Hop Lyon, Hematol, Pierre Benite, France

[3] Ctr Hosp Univ Dijon, Serv Hematol Clin, INSERM, Unite Mixte Rech UMR 1231, Dijon, France

[4] Lymphoma Acad Res Org, Stat, Pierre Benite, France

[5] Inst Portuges Oncol, Lisbon, Portugal

[6] Univ Nancy, Ctr Hosp, Hematol, Nancy, France

[7] Univ Lille, Ctr Hosp Univ Lille, Hematol, Grp Rech Formes Injectables & Technol Assoc,EA 73, Lille, France

[8] Univ Sydney, Concord Repatriat Gen Hosp, Concord, NSW, Australia

[9] Univ Sydney, Concord, NSW, Australia

[10] Paracelsus Med Univ Salzburg, Ctr Clin Canc & Immunol Trials, Canc Cluster Salzburg, Salzburg Canc Res Inst, Salzburg, Austria

[11] Hosp Univ Salamanca, Salamanca, Spain

[12] Med Univ Silesia, Dept Hematol & Canc Prevent, Katowice, Poland

[13] Algemeen Ziekenhuis Groeninge Hosp, Campus Marias Voorzienigheid, Brugge, Belgium

[14] Univ Paris Est, INSERM U955, Henri Mondor Hosp, Assistance Publ Hop Paris,Dept Pathol, Creteil, France

[15] Hop Henri Mond, Assistance Publ Hop Paris, Unite Hemopathies Lymphoides, Creteil, France

[16] Univ Paris, NF KappaB, Differenciat & Canc, Paris, France

来源：

BLOOD ADVANCES | 2021年 / 5卷 / 15期

关键词：

B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; ELDERLY-PATIENTS; RISK-FACTORS; AGGRESSIVE LYMPHOMA; CNS PROPHYLAXIS; RITUXIMAB; MULTICENTER; IMPACT;

D O I：

10.1182/bloodadvances.2021004766

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2965 / 2968

页数：4

共 24 条

[1]

Bernard S, 2018, HEMASPHERE, V2, P85

[2] Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516-The Southwest Oncology Group [J].

Bernstein, Steven H. ;

Unger, Joseph M. ;

LeBlanc, Michael ;

Friedberg, Jonathan ;

Miller, Thomas P. ;

Fisher, Richard I. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) :114-119

[3] Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL) [J].

Boehme, V. ;

Zeynalova, S. ;

Kloess, M. ;

Loeffler, M. ;

Kaiser, U. ;

Pfreundschuh, M. ;

Schmitz, N. .

ANNALS OF ONCOLOGY, 2007, 18 (01) :149-157

[4] CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) [J].

Boehme, Volkmar ;

Schmitz, Norbert ;

Zeynalova, Samira ;

Loeffler, Markus ;

Pfreundschuh, Michael .

BLOOD, 2009, 113 (17) :3896-3902

[5] A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma [J].

Cheah, C. Y. ;

Herbert, K. E. ;

O'Rourke, K. ;

Kennedy, G. A. ;

George, A. ;

Fedele, P. L. ;

Gilbertson, M. ;

Tan, S. Y. ;

Ritchie, D. S. ;

Opat, S. S. ;

Prince, H. M. ;

Dickinson, M. ;

Burbury, K. ;

Wolf, M. ;

Januszewicz, E. H. ;

Tam, C. S. ;

Westerman, D. A. ;

Carney, D. A. ;

Harrison, S. J. ;

Seymour, J. F. .

BRITISH JOURNAL OF CANCER, 2014, 111 (06) :1072-1079

[6] The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy [J].

El-Galaly, Tarec Christoffer ;

Villa, Diego ;

Michaelsen, Thomas Yssing ;

Hutchings, Martin ;

Mikhaeel, Nabegh George ;

Savage, Kerry J. ;

Sehn, Laurie H. ;

Barrington, Sally ;

Hansen, Jakob W. ;

Smith, Daniel ;

Rady, Kirsty ;

Mylam, Karen J. ;

Larsen, Thomas S. ;

Holmberg, Staffan ;

Juul, Maja B. ;

Cordua, Sabrina ;

Clausen, Michael R. ;

Jensen, Kristina B. ;

Johnsen, Hans E. ;

Seymour, John F. ;

Connors, Joseph M. ;

Brown, Peter de Nully ;

Bogsted, Martin ;

Cheah, Chan Y. .

EUROPEAN JOURNAL OF CANCER, 2017, 75 :195-203

[7] Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review [J].

Eyre, Toby A. ;

Djebbari, Faouzi ;

Kirkwood, Amy A. ;

Collins, Graham P. .

HAEMATOLOGICA, 2020, 105 (07) :1914-1924

[8] Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era [J].

Ferreri, Andres J. M. ;

Bruno-Ventre, Marta ;

Donadoni, Giovanni ;

Ponzoni, Maurilio ;

Citterio, Giovanni ;

Foppoli, Marco ;

Vignati, Alessandro ;

Scarfo, Lydia ;

Sassone, Marianna ;

Govi, Silvia ;

Caligaris-Cappio, Federico .

BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (05) :654-662

[9] Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA) [J].

Ghesquieres, H. ;

Chevrier, M. ;

Laadhari, M. ;

Chinot, O. ;

Choquet, S. ;

Molucon-Chabrot, C. ;

Beauchesne, P. ;

Gressin, R. ;

Morschhauser, F. ;

Schmitt, A. ;

Gyan, E. ;

Hoang-Xuan, K. ;

Nicolas-Virelizier, E. ;

Cassoux, N. ;

Touitou, V ;

Le Garff-Tavernier, M. ;

Savignoni, A. ;

Turbiez, I ;

Soumelis, V ;

Houillier, C. ;

Soussain, C. .

ANNALS OF ONCOLOGY, 2019, 30 (04) :621-628

[10] Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma [J].

Gribben, John G. ;

Fowler, Nathan ;

Morschhauser, Franck .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2803-U127

← 1 2 3 →